Table 2.
Variable | Ipsilateral catheter | Contralateral catheter | P value |
---|---|---|---|
No. of patients | 69 | 164 | |
Age (y) | 54 ± 14 | 51 ± 15 | 0.2 |
Male sex | 41 (59%) | 87 (53%) | 0.4 |
Black race | 56 (81%) | 128 (78%) | 0.6 |
Diabetes | 40 (58%) | 69 (42%) | 0.03 |
Hypertension | 58 (84%) | 149 (91%) | 0.1 |
CAD | 18 (26%) | 27 (16%) | 0.09 |
PVD | 12 (17%) | 14 (9%) | 0.05 |
CVD | 13 (19%) | 16 (11%) | 0.06 |
CHF | 24 (35%) | 25 (15%) | 0.008 |
AVF location | 0.4 | ||
Forearm | 38 (55%) | 101 (62%) | |
Upper arm | 31 (45%) | 63 (38%) | |
AVF side | <0.001 | ||
Left | 27 (39%) | 156 (95%) | |
Right | 42 (61%) | 8 (5%) | |
Catheter side | <0.001 | ||
Left | 27 (39%) | 8 (5%) | |
Right | 42 (61%) | 156 (95%) |
Values for continuous variables given as mean +/− SD; values for categorical variables given as number (percentage). AVF had to have been placed after initiation of hemodialysis.
CAD, coronary artery disease; PVD, peripheral vascular disease; CVD, cerebrovascular disease, CHF, congestive heart failure; AVF, arteriovenous fistula.